LivaNova PLC (NASDAQ:LIVN) – Jefferies Financial Group issued their FY2023 earnings per share estimates for LivaNova in a note issued to investors on Wednesday, July 31st. Jefferies Financial Group analyst R. Denhoy anticipates that the company will post earnings per share of $4.69 for the year.
LivaNova (NASDAQ:LIVN) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $0.56 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.59 by ($0.03). The company had revenue of $277.20 million during the quarter, compared to analysts’ expectations of $275.14 million. LivaNova had a positive return on equity of 8.56% and a negative net margin of 23.86%. The company’s revenue for the quarter was down 3.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.96 EPS.
Shares of LIVN opened at $78.68 on Monday. The business has a 50-day moving average of $73.68. The stock has a market cap of $3.82 billion, a PE ratio of 29.15, a P/E/G ratio of 3.32 and a beta of 0.56. LivaNova has a 1-year low of $64.80 and a 1-year high of $131.54. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.95 and a quick ratio of 0.67.
In other LivaNova news, CEO Damien Mcdonald sold 1,000 shares of LivaNova stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $73.58, for a total transaction of $73,580.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Thad Allen Huston sold 2,000 shares of LivaNova stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $75.00, for a total value of $150,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,300 shares of company stock worth $387,999. Company insiders own 0.41% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in LIVN. Oakbrook Investments LLC acquired a new stake in shares of LivaNova during the 2nd quarter valued at about $245,000. FTB Advisors Inc. acquired a new stake in shares of LivaNova during the 1st quarter valued at about $216,000. Retirement Systems of Alabama lifted its holdings in shares of LivaNova by 0.5% during the 1st quarter. Retirement Systems of Alabama now owns 63,376 shares of the company’s stock valued at $6,163,000 after buying an additional 303 shares during the last quarter. Strs Ohio lifted its holdings in shares of LivaNova by 1.1% during the 1st quarter. Strs Ohio now owns 18,700 shares of the company’s stock valued at $1,818,000 after buying an additional 200 shares during the last quarter. Finally, Creative Financial Designs Inc. ADV acquired a new stake in shares of LivaNova during the 1st quarter valued at about $29,000. 83.95% of the stock is currently owned by institutional investors.
LivaNova Company Profile
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV?) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients.
Further Reading: Should You Consider an Index Fund?
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.